Stock AnalizBladex, Inc. BLX
Commercial Banks · IPO 1992 · data as of November 13, 2026
Bladex, Inc. (BLX) is a financial company listed in the US with a market value of about $1.9B. In the twelve months to September 30, 2026 it had revenue of $346M and net income of $242M, a net margin of 69.9%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is value (5/5); the weakest is financial health (1/5).
Key numbers: a P/E of 7.8, a price to free cash flow of 6.5, 5-year revenue growth of 19% a year, a 5-year average ROIC of 3%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 17% above the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
Checks not passed
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
- ROE above 15%
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $346M | $316M | $304M | $266M | $167M | $104M | $99M | $127M | $128M | $138M | $168M |
| Net income | $242M | $227M | $206M | $166M | $92M | $63M | $64M | $86M | $11M | $82M | $87M |
| Free cash flow | $292M | $777M | -$124M | $1.1B | -$771M | -$872M | $1.2B | -$93M | -$174M | $714M | $780M |
| EPS (diluted) | $6.45 | $6.11 | $5.48 | $4.42 | $2.45 | $1.67 | $1.69 | $2.29 | $0.30 | $2.18 | $2.32 |
| Net margin | 69.9% | 71.9% | 67.8% | 62.4% | 55.2% | 60.2% | 64.1% | 67.9% | 8.7% | 59.3% | 51.8% |
| ROIC | — | — | 4.2% | 3.8% | 2.4% | 1.9% | 2.6% | 2.4% | 2.2% | 3.4% | 3.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $69.65, 38% above the current price; targets range from $66.60 to $73.00; the consensus rating is “Strong buy”; expected EPS is $6.47 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Bladex’s P/E ratio?
About 7.8, based on the last twelve months of diluted earnings per share (forward P/E about 7.3).
Is Bladex stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 17% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Bladex pay a dividend?
Yes. The dividend yield is about 5.44%, and it has paid dividends for 10 years in our data.
Is Bladex a good stock to buy?
We do not give buy or sell advice. Bladex scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.